It happened again on Thursday morning, when Cigna Group reported quarterly earnings. The results missed estimates and ...

Cigna Group plans to make changes to help lower out-of-pocket cost of prescription drugs, the company said on Wednesday, as ...

Cigna forecast annual profit below Wall Street expectations on Thursday and missed estimates for the fourth quarter, as ...

Raymond James analyst John Ransom lowered the firm’s price target on Cigna (CI) to $360 from $415 and keeps a Strong Buy rating on the shares.

Cantor Fitzgerald lowered the firm’s price target on Cigna (CI) to $350 from $400 and keeps an Overweight rating on the shares. Cantor is ...

Cigna Group CEO David Cordani said the company will make investments this year to improve patient and provider experiences ...

Cigna blamed lower-than-expected fourth-quarter returns on its stop-loss insurance business that insures employers from ...

Cigna Group plans to limit patients’ out-of-pocket expenses for medications as the insurer faces pressure from Washington ...

Cigna Group shares fell sharply after the health insurer reported fourth-quarter profit that was dragged down by medical ...

Cigna (CI) stock falls as the managed care company's Q4 2024 earnings miss the consensus due to an unexpected rise in medical ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and make those costs more transparent.